Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value

$3.00+0.07 (+2.39%)

Close on Nov 11, 2026Market cap $126.37MP/E –Yield –

Apyx Medical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Apyx Medical's EV/EBITDA was 68.9× on Jul 31, 2013, against 67.8× a year earlier. Over the last 3 years it ranged from 19.6× to 296.6×, with a median of 66.5×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2013	Jul 31, 2013	68.9×	−95.1
2012	Dec 31, 2012	163.9×	+97.4
2011	Dec 30, 2011	66.5×	+30.8
2010	Dec 31, 2010	35.7×	–

Where these numbers come from

Parsed from the XBRL in Apyx Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing